Transcriptional repression of caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings

American Journal of Pathology

Volumn 178, Issue 5, 2011, Pages 2236-2251

  Boopathi, Ettickan ^a   Gomes, Cristiano Mendes ^b   Goldfarb, Robert ^a   John, Mary ^a   Srinivasan, Vittala Gopal ^a   Alanzi, Jaber ^a   Malkowicz, S Bruce ^a   Kathuria, Hasmeena ^c   Zderic, Stephen A ^d   Wein, Alan J ^a   Chacko, Samuel ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 6;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER DISEASE; BLADDER MUSCLE; BLADDER SMOOTH MUSCLE HYPERTROPHY; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; MUSCLE HYPERTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 79959256001     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.01.038     Document Type: Article

References (64)

1. Wein AJ: Pathophysiology and categorization of voiding dysfunction. Campbell's Urology. Edited by PC Walsh, AB Retik, DE Vaughan, AJ Wein. Philadelphia, PA, Saunders, 1998, pp 917-926
2. Abrams P, Donovan JL, de la Rosette JJ, Schäfer W: International Continence Society "Benign Prostatic Hyperplasia" Study: background, aims, and methodology. Neurourol Urodyn 1997, 16:79-91
3. DiSanto ME, Stein R, Chang S, Hypolite JA, Zheng Y, Zderic S, Wein AJ, Chacko S: Alteration in the expression of myosin isoforms in detrusor smooth muscle following bladder outlet obstruction. Am J Physiol Cell Physiol 2003, 285:C1397-C1410 (Pubitemid 37429614)
4. Bing W, Chang S, Hypolite JA, DiSanto ME, Zderic SA, Rolf L, Wein AJ, Chacko S: Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase. Am J Physiol Renal Physiol 2003, 285:F990-F997 (Pubitemid 37288645)
5. Levin RM, Haugaard N, O'Connor L, Buttyan R, Das A, Dixon JS, Gosling JA: Obstructive response of human bladder to BPH vs. rabbit bladder response to partial outlet obstruction: a direct comparison. Neurourol Urodyn 2000, 19:609-629
6. Polyák E, Boopathi E, Mohanan S, Deng M, Zderic SA, Wein AJ, Chacko S: Alterations in caveolin expression and ultrastructure after bladder smooth muscle hypertrophy. J Urol 2009, 182:2497-2503
7. Galbiati F, Razani B Lisanti MP: Emerging themes in lipid rafts and caveolae. Cell 2001, 106:403-411 (Pubitemid 32786984)
8. Fielding CJ, Fielding PE: Relationship between cholesterol trafficking and signaling in rafts and caveolae. Biochim Biophys Acta (BBA)-Biomembranes 2003, 1610:219-228 (Pubitemid 36324466)
9. Okamoto T, Schlege A, Scherer PE, Lisanti MP: Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 1998, 273:5419-5422
10. Razani B, Lisanti MP: Caveolin-deficient mice: insights into caveolar function human disease. J Clin Invest 2001, 108:1553-1561 (Pubitemid 33144862)
11. Couet S, Li T, Okamoto T, Ikezu, Lisanti MP: Identification of peptide and protein ligands for the caveolin-scaffolding domain: implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 1997, 272:6525-6533 (Pubitemid 27118133)
12. Bist A, Fielding PE, Fielding CJ: Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc Natl Acad Sci USA 1997, 94:10693-10698 (Pubitemid 27430796)
13. van den Heuvel AP, Schulze A, Burgering BM: Direct control of caveolin-1 expression by FOXO transcription factors. Biochem J 2005; 385:795-802 (Pubitemid 40208841)
14. Molkentin JD: The zinc finger-containing transcription factors GATA-4, -5, and -6: ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 2000, 275:38949-38952
15. Burch JB: Regulation of GATA gene expression during vertebrate development. Semin Cell Dev Bio 2005, 16:71-81
16. Orkin SH: GATA-binding transcription factors in hematopoietic cells. Blood 1992, 80:575-581
17. Ko LJ, Engel JD: DNA-binding specificities of the GATA transcription factor family. Mol Cell Biol 1993, 13:4011-4022 (Pubitemid 23187629)
18. Sakai Y, Nakagawa R, Sato R, Maeda M: Selection of DNA binding sites for human transcriptional regulator GATA-6. Biochem Biophys Res Commun 1998, 250:682-688 (Pubitemid 28484788)
19. Chang DF, Belaguli NS, Iyer D, Roberts WB, Wu SP, Dong XR, Marx JG, Moore MS, Beckerle MC, Majesky MW, Schwartz RJ: Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev Cell 2003, 4:107-118 (Pubitemid 36105337)
20. Yin F, Herring BP: GATA-6 can act as a positive or negative regulator of smooth muscle-specific gene expression. J Biol Chem 2005, 280:4745-4752 (Pubitemid 40288645)
21. Shirvani S, Xiang F, Koibuchi N, Chin MT: CHF1/Hey2 suppresses SM-MHC promoter activity through an interaction with GATA-6. Biochem Biophys Res Commun 2006, 339:151-156 (Pubitemid 41697528)
22. Kanematsu A, Ramachandran A, Adam RM: GATA-6 mediates human bladder smooth muscle differentiation: involvement of a novel enhancer element in regulating alpha-smooth muscle actin gene expression. Am J Physiol Cell Physiol 2007, 293:C1093-C1102 (Pubitemid 47437382)
23. Lepore JJ, Cappola TP, Mericko PA, Morrisey EE, Parmacek MS: GATA-6 regulates genes promoting synthetic functions in vascular SMCs. Arterioscle Thromb Vasc Biol 2005, 25:309-314 (Pubitemid 40189150)
24. Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE, Molkentin JD: The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 2001, 276:30245-30253
25. Morrisey EE, Ip HS, Lu MM, Parmacek MS: GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm. Dev Biol 1996, 177:309-322 (Pubitemid 26252501)
26. Patel HH, Zhang S, Murray F, Suda RY, Head BP, Yokoyama U, Swaney JS, Niesman IR, Schermuly RT, Pullamsetti SS, Thistlethwaite PA, Miyanohara A, Farquhar MG, Yuan JX, Insel PA: Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. FASEB J 2007, 11:2970-2979 (Pubitemid 47372763)
27. Lipardi C, Mora R, Colomer V, Paladino S, Nitsch L, Rodriguez-Boulan E, Zurzolo C: Caveolin transfection results in caveolae formation but not apical sorting of glycosylphosphatidylinositol (GPI)-anchored proteins in epithelial cells. J Cell Biol 1998, 140:617-626 (Pubitemid 28134064)
28. Stehr M, Adam RM, Khoury J, Zhuang L, Solomon KR, Peters CA, Freeman MR: Platelet derived growth factor-BB is a potent mitogen for rat ureteral and human bladder SMCs: dependence on lipid rafts for cell signaling. J Urol 2003, 169:1165-1170 (Pubitemid 36188194)
29. Stehr M, Estrada CR, Khoury J, Danciu TE, Sullivan MP, Peters CA, Solomon KR, Freeman MR, Adam RM: Caveolae are negative regulators of transforming growth factor-beta1 signaling in ureteral SMCs. J Urol 2004, 172:2451-2455 (Pubitemid 39507551)
30. Woodman SE, Cheung MW, Tarr M, North AC, Schubert W, Lagaud G, Marks CB, Russell RG, Hassan GS, Factor SM, Christ GJ, Lisanti MP: Urogenital alterations in aged male caveolin-1 knockout mice. J Urol 2004, 171:950-957 (Pubitemid 38090540)
31. Cao G, Yang G, Timme TL, Saika T, Truong LD, Satoh T, Goltsov A, Park SH, Men T, Kusaka N, Tian W, Ren C, Wang H, Kadmon D, Cai WW, Chinault AC, Boone TB, Bradley A, Thompson TC: Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis. Am J Pathol 2003, 162:1241-1248 (Pubitemid 36350668)
32. Koleske AJ, Baltimore D, Lisanti MP: Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 1995, 92:1381-1385
33. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV: Loss of caveolae: vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001, 293:2449-2452 (Pubitemid 32917325)
34. Rahman A, Swärd K: The role of caveolin-1 in cardiovascular regulation. Acta Physiol (Oxf) 2009, 195:231-245
35. Austin JC, Chacko SK, DiSanto M, Canning DA, Zderic SA: A male murine model of partial bladder outlet obstruction reveals changes in detrusor morphology, contractility and myosin isoform expression. J Urol 2004, 172:1524-1528 (Pubitemid 39249762)
36. Abrams P: Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 1999, 84:14-15
37. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A: The standardization of terminology of lower urinary tract function: report from the Standardization Sub-Committee of the International Continence Society. Neurourol Urodyn 2002, 21:167-178 (Pubitemid 34195211)
38. Griffiths D, Hofner K, van MR, Rollema HJ, Spangberg A, Gleason D: Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies. Neurourol Urodyn 1997, 16:1-18 (Pubitemid 27053287)
39. Schreiber E, Matthias P, Muller MM. Schaffner W: Rapid detection of octamer binding proteins with "mini-extracts" prepared from a small number of cells. Nucleic Acids Res 1989, 17:6419-6424
40. Zhang E, Stein R, Chang S, Zheng Y, Zderic SA, Wein AJ, Chacko S: Smooth muscle hypertrophy following partial bladder outlet obstruction is associated with overexpression of non-muscle caldesmon. Am J Pathol 2000, 164:601-612 (Pubitemid 38364675)
41. Masternak KA, Muhlethaler-Mottet J, Villard M, Zufferey V, Steimle R, Reith W: CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev 2000, 14:1156-1166
42. Kadonaga JT, Tjian R: Affinity purification of sequence-specific DNA binding proteins. Proc Natl Acad Sci USA 1986; 83:5889-5893 (Pubitemid 16000619)
43. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983, 11:1475-1489
44. O'Neill LP, Turner BM: Histone H4 acetylation distinguishes coding regions of the human genome from heterochromatin in a differentiation-dependent but transcription-independent manner. EMBO J 1995, 14:3946-3957
45. Okada T, Ramsey WJ, Munir J, Wildner O, Blaese RM: Efficient directional cloning of recombinant adenovirus vectors using DNA-protein complex. Nucleic Acids Res 1998, 26:1947-1950 (Pubitemid 28291727)
46. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T: Matlnspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21:2933-2942, [Epub ahead of press April 28, 2005]
47. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD: Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003, 9:493-501
48. Bist J, Fielding C, Fielding PE: p53 Regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism. Biochemistry 2000, 39:1966-1972 (Pubitemid 30124004)
49. Roy UK, Henkhaus RS, Ignatenko NA, Mora M, Fultz KE, Gerner EW: Wild-type APC regulates caveolin-1 expression in human colon adenocarcinoma cell lines via FOXO1a and C-myc. Mol Carcinog 2008, 47:947-955
50. Kathuria H, Cao YX, Ramirez MI, Williams MC: Transcription of the caveolin-1 gene is differentially regulated in lung type I epithelial and endothelial cell lines: a role for ETS proteins in epithelial cell expression. J Biol Chem 2004, 279:30028-30036 (Pubitemid 38937923)
51. Sloan KA, Marquez HA, Li J, Cao Y, Hinds A, O'Hara CJ, Kathuria S, Ramirez MI, Williams MC, Kathuria H: Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines. Carcinogenesis 2009, 30:1433-1442
52. Fong A, Garcia E, Gwynn L, Lisanti MP, Fazzari MJ, Li M: Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Am J Clin Pathol 2003, 120:93-100 (Pubitemid 37046375)
53. Rajjayabun PH, Garg S, Durkan GC, Charlton R, Robinson MC, Mellon JK: Caveolin-1 expression is associated with high-grade bladder cancer. Urology 2001, 58:811-814
54. Thomas S, Overdevest JB, Nitz MD, Williams PD, Owens CR, Sanchez-Carbayo M, Frierson HF Jr, Schwartz MA, Theodorescu D: Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer. Cancer Res 2010, 71:832-841
55. Cho DS, Yim H, Cho KS, Hong SJ, Cho NH, Kim SI, Ahn HS, Kim SJ: Impact of caveolin-1 expression on the prognosis of transitional cell carcinoma of the upper urinary tract. J Korean Med Sci 2008, 23:296-301
56. Kunze E, Von Bonin F, Werner C, Wendt M, Schlott T: Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements. Int J Mol Med 2006, 17:3-13
57. Hanke M, Kausch I, Dahmen G, Jocham D, Warnecke JM: Detailed technical analysis of urine RNA-based tumor diagnostics reveals ETS2/urokinase plasminogen activator to be a novel marker for bladder cancer. Clin Chem 2007, 53:2070-2077 (Pubitemid 350197289)
58. Lee SJ, Park SS, Cho YH, Park K, Kim EJ, Jung KH, Kim SK, Kim WJ, Moon SK: Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: the role of MAP kinase signaling pathways. Oncol Rep 2008, 19:1007-1013 (Pubitemid 351802673)
59. Morrisey EE, Ip HS, Tang Z, Lu MM, Parmacek MS: GATA-5: a transcriptional activator expressed in a novel temporally and spatially-restricted pattern during embryonic development. Dev Biol 1997, 183:21-36 (Pubitemid 27157830)
60. Cohen AW, Park DS, Woodman SE, Williams TM, Chandra M, Shirani J, Pereira de Souza A, Kitsis RN, Russell RG, Weiss LM, Tang B, Jelicks LA, Factor SM, Shtutin V, Tanowitz HB, Lisanti MP: Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol 2003, 284:C457-C474 (Pubitemid 36120083)
61. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP: Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo: role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 2004, 279:51630-51646 (Pubitemid 40017914)
62. Williams TM, Lisanti MP: Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005, 288:C494-C506 (Pubitemid 40229478)
63. Bergdahl A, Swärd K: Caveolae-associated signaling in smooth muscle. Can J Physiol Pharmacol 2004, 82:289-299
64. Lee YH, Hwang MK, Morgan KG, Taggart MJ: Receptor-coupled contractility of uterine smooth muscle: from membrane to myofilaments. Exp Physiol 2001, 86:283-288 (Pubitemid 32266462)